期刊文献+

结直肠癌免疫治疗 被引量:1

Immunotherapy of Colorectal Cancer
下载PDF
导出
摘要 目的探讨结直肠癌免疫治疗的现状与研究进展。方法采用文献回顾的方法对结直肠癌免疫治疗现状及其研究进展进行综述。结果结直肠癌免疫治疗的研究内容及主要方法包括:主动非特异性免疫治疗、过继免疫治疗、单克隆抗体(mAb)治疗、主动特异性免疫治疗、导向治疗等。结论免疫治疗为手术和放(或)化疗的有益补充治疗,在结直肠癌综合治疗中发挥着重要的辅助作用。 Objective To generally analyze the current situations and advancement of the study on immunotherapy for colorectal cancer. Methods The pertinent published papers about the current situation and research advancement of the immunotherapy of colorectal cancer were retrospectively investigated. And also the immunogenicity and the varying principles of immunoresistance, the functional targets, the practicality, and some other characteristics of different immunotherapy for colorectal cancer were reviewed. Results The main treatments and the research focuses in the immunotherapy of colorectal cancer are initiative nonspecific immunotherapy, adoptive immunotherapy, monoclonal antibody immunotherapy, initiative specific immunotherapy, and targeted therapy. They work by fighting against the cancer itself, cutting off the tumor's nutrition supply, activating the immune system specifically or breaking the immune tolerance and so on. Though there are still many problems unsolved, immunotherapy has a promising clinical prospect. Conclusion As a beneficial complement for surgery, chemotherapy and radiotherapy, immunotherapy plays an important auxiliary role in the combined therapy for colorectal cancer.
出处 《中国普外基础与临床杂志》 CAS 2006年第3期358-361,共4页 Chinese Journal of Bases and Clinics In General Surgery
关键词 结直肠癌 免疫治疗 Colorectal cancer Immunotherapy
  • 相关文献

参考文献27

  • 1Foon KA,Yannelli J,Bhattacharya-Chatterjee M.Colorectal cancer as a model for immunotherapy[J].Clin Cancer Res,1999; 5(2):225.
  • 2Yip D,Strickland AH,Karapetis CS,et al.Immunomodulation therapy in colorectal carcinoma[J].Cancer Treat Rev,2000; 26(3):169.
  • 3Todryk SM,Chong H,Vile RG,et al.Can immunotherapy by gene transfer tip the balance against colorectal cancer?[J].Gut,1998; 43(4):445.
  • 4Mann B,Gratchev A,Bohm C,et al.FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas[J].Br J Cancer,1999; 79(7-8):1262.
  • 5Somasundaram R,Jacob L,Swoboda R,et al.Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta[J].Cancer Res,2002; 62(18):5267.
  • 6Smith RE,Colangelo L,Wieand HS,et al.Randomized trial of adjuvant therapy in colon carcinoma:10-year results of NSABP protocol C-01[J].J Natl Cancer Inst,2004; 96(15):1128.
  • 7Brivio F,Lissoni P,Alderi G,et al.Preoperative interleukin-2 subcutaneous immunotherapy may prolong the survival time in advanced colorectal cancer patients[J].Oncology,1996; 53(4):263.
  • 8Moertel CG,Fleming TR,Macdonald JS,et al.Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage Ⅲ colon carcinoma:a final report[J].Ann Intern Med,1995; 122(5):321.
  • 9Rosenberg SA,Lotze MT,Yang JC,et al.Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients[J].Ann Surg,1989; 210(4):474.
  • 10Dummer W,Niethammer AG,Baccala R,et al.T cell homeostatic proliferation elicits effective antitumor autoimmunity[J].J Clin Invest,2002; 110(2):185.

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部